eIF2α phosphorylation as a biomarker of immunogenic cell death.

Seminars in Cancer Biology
Oliver KeppL Galluzzi

Abstract

Cancer cells exposed to some forms of chemotherapy and radiotherapy die while eliciting an adaptive immune response. Such a functionally peculiar variant of apoptosis has been dubbed immunogenic cell death (ICD). One of the central events in the course of ICD is the activation of an endoplasmic reticulum (ER) stress response. This is instrumental for cells undergoing ICD to emit all the signals that are required for their demise to be perceived as immunogenic by the host, and culminates with the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α). In particular, eIF2α phosphorylation is required for the pre-apoptotic exposure of the ER chaperone calreticulin (CALR) on the cell surface, which is a central determinant of ICD. Importantly, phosphorylated eIF2α can be quantified in both preclinical and clinical samples by immunoblotting or immunohistochemistry using phosphoneoepitope-specific monoclonal antibodies. Of note, the phosphorylation of eIF2α and CALR exposure do not necessarily correlate with each other, and neither of these parameters is sufficient for cell death to be perceived as immunogenic. Nonetheless, accumulating data indicate that assessing the degree of phosphorylation of eIF2α provides a con...Continue Reading

References

Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J SiekierkaS Ochoa
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R L MattsI M London
Jul 12, 2002·Nature·Paola ScaffidiMarco E Bianchi
Oct 1, 2003·Molecular and Cellular Biology·Sara B CullinanJ Alan Diehl
Feb 7, 2004·The Journal of Biological Chemistry·Kristen R TaylorRichard L Gallo
Jul 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Krishna M Vattem, Ronald C Wek
Aug 18, 2004·Molecular and Cellular Biology·Jaime D BlaisJohn C Bell
Oct 4, 2005·The Journal of Clinical Investigation·Chunyan XuJohn C Reed
Dec 21, 2005·The Journal of Experimental Medicine·Noelia CasaresGuido Kroemer
Jan 13, 2006·Nature·Fabio MartinonJürg Tschopp
Jul 11, 2006·Science·Julie Hollien, Jonathan S Weissman
Dec 26, 2006·Nature Medicine·Michel ObeidGuido Kroemer
Sep 25, 2007·Cell·Nicole L SoliminiStephen J Elledge
Nov 6, 2007·Immunological Reviews·Marco E Bianchi, Angelo A Manfredi
Nov 9, 2007·The Journal of Investigative Dermatology·Yiqun G ShellmanDavid A Norris
Jun 17, 2008·Current Opinion in Immunology·Pascale JeanninYves Delneste
Aug 2, 2008·Nature Reviews. Immunology·Derrich J ToddLaurie H Glimcher
Oct 11, 2008·Cell Death and Differentiation·J ThorburnA Thorburn
Jan 24, 2009·The EMBO Journal·Theocharis PanaretakisGuido Kroemer
Aug 5, 2009·The Journal of Cell Biology·Julie HollienJonathan S Weissman
Oct 27, 2009·Cell Cycle·Isabelle MartinsGuido Kroemer
May 4, 2010·Journal of Internal Medicine·L GalluzziG Kroemer
Jun 2, 2010·Oncogene·T RzymskiA L Harris
Oct 23, 2010·Molecular Cell·Guido KroemerBeth Levine
Nov 13, 2010·Cell Death and Differentiation·I VitaleG Kroemer
Jan 21, 2011·Cancer Metastasis Reviews·Oliver KeppGuido Kroemer
Feb 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raquel AguileraFlavio Salazar-Onfray
Feb 22, 2011·Trends in Immunology·Dmitri V KryskoPeter Vandenabeele
Mar 3, 2011·Nature Cell Biology·Ira Tabas, David Ron
Apr 30, 2011·Nature Reviews. Molecular Cell Biology·Ilio VitaleGuido Kroemer
Aug 31, 2011·PloS One·Xu XuDouglas R Cavener

❮ Previous
Next ❯

Citations

Nov 17, 2015·International Journal of Molecular Sciences·Mladen KorbelikKyi Min Saw
Dec 31, 2015·Proceedings of the National Academy of Sciences of the United States of America·Aude De GassartFabio Martinon
Jul 16, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hifzur R SiddiqueKeigo Machida
Nov 28, 2015·Current Problems in Cancer·G Daniel GrassSungjune Kim
Apr 7, 2016·Cellular and Molecular Life Sciences : CMLS·Lorenzo GalluzziGuido Kroemer
Aug 25, 2015·Frontiers in Immunology·Jitka FucikovaRadek Spisek
May 11, 2015·Seminars in Cancer Biology·Claudio Hetz, Eric Chevet
Mar 25, 2018·Molecular Carcinogenesis·Qiang WangXiaoli Ju
Jan 25, 2018·Cell Death and Differentiation·Lorenzo GalluzziGuido Kroemer
Dec 22, 2019·Biomolecules·Cédric RébéFrançois Ghiringhelli
Mar 30, 2020·Journal for Immunotherapy of Cancer·Yan WangGuido Kroemer
May 28, 2020·Cancers·Antonio Di GraziaCarmine Stolfi
Apr 19, 2018·Frontiers in Immunology·Brianne CruickshankShashi Gujar
Jul 26, 2019·International Journal of Cancer. Journal International Du Cancer·Lucie DemontouxCédric Rébé
Mar 28, 2020·Molecular Carcinogenesis·Hang RuanJian Yu
Feb 22, 2018·Physiological Reviews·Maysa SarhanAndreas Linkermann
Jul 1, 2020·Chemical Society Reviews·A Paden King, Justin J Wilson
Aug 17, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·W G LandA Linkermann
Jul 15, 2020·BMC Cancer·Ana Carolina Martínez-TorresCristina Rodríguez-Padilla
Jun 23, 2018·Frontiers in Immunology·Larissa O C P RodriguesLeticia A M Carneiro
Aug 8, 2019·Breast Cancer Research and Treatment·Jichao HeBob van de Water
Oct 24, 2019·Cell Death & Disease·Vinay SagarSarki A Abdulkadir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.